Nomad Power Solutions, Inc. (NMAD)
3.46
-0.03
(-0.86%)
USD |
NASDAQ |
Nov 06, 10:20
Nomad Power Solutions EPS Diluted (Quarterly) : -0.1623 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1623 |
| March 31, 2026 | -0.1783 |
| December 31, 2025 | -0.3308 |
| September 30, 2025 | -0.3291 |
| June 30, 2025 | -0.2851 |
| March 31, 2025 | -0.2871 |
| December 31, 2024 | -0.2746 |
| September 30, 2024 | -0.4384 |
| June 30, 2024 | -0.4494 |
| March 31, 2024 | -0.4318 |
| December 31, 2023 | -0.4589 |
| September 30, 2023 | -0.491 |
| June 30, 2023 | -1.001 |
| March 31, 2023 | -0.8214 |
| December 31, 2022 | -0.9799 |
| September 30, 2022 | -0.8879 |
| June 30, 2022 | -0.9545 |
| March 31, 2022 | -1.205 |
| December 31, 2021 | -1.476 |
| September 30, 2021 | -0.9019 |
| June 30, 2021 | -1.271 |
| March 31, 2021 | -1.353 |
| December 31, 2020 | -0.7313 |
| September 30, 2020 | -1.433 |
| June 30, 2020 | -0.3342 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3432 |
| December 31, 2019 | -0.288 |
| September 30, 2019 | -0.9654 |
| June 30, 2019 | -0.5466 |
| March 31, 2019 | -0.3834 |
| December 31, 2018 | -0.312 |
| September 30, 2018 | -1.069 |
| June 30, 2018 | -0.60 |
| March 31, 2018 | -0.60 |
| December 31, 2017 | -0.60 |
| September 30, 2017 | -0.60 |
| June 30, 2017 | -0.60 |
| March 31, 2017 | -0.60 |
| December 31, 2016 | -0.60 |
| September 30, 2016 | -0.60 |
| June 30, 2016 | -0.60 |
| March 31, 2016 | -0.60 |
| December 31, 2015 | -0.60 |
| September 30, 2015 | -1.20 |
| June 30, 2015 | -0.60 |
| March 31, 2015 | -1.20 |
| December 31, 2014 | -0.7842 |
| September 30, 2014 | -0.60 |
| June 30, 2014 | -1.20 |
| March 31, 2014 | -1.20 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.344M |
| Total Expenses (Quarterly) | 2.187M |
| Enterprise Value | 43.31M |
| Earnings Yield | -28.92% |
| Normalized Earnings Yield | -28.31 |